BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 14594802)

  • 1. Lymphoid enhancer factor-1 links two hereditary leukemia syndromes through core-binding factor alpha regulation of ELA2.
    Li FQ; Person RE; Takemaru K; Williams K; Meade-White K; Ozsahin AH; Güngör T; Moon RT; Horwitz M
    J Biol Chem; 2004 Jan; 279(4):2873-84. PubMed ID: 14594802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil elastase is severely down-regulated in severe congenital neutropenia independent of ELA2 or HAX1 mutations but dependent on LEF-1.
    Skokowa J; Fobiwe JP; Dan L; Thakur BK; Welte K
    Blood; 2009 Oct; 114(14):3044-51. PubMed ID: 19620402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural analyses of DNA recognition by the AML1/Runx-1 Runt domain and its allosteric control by CBFbeta.
    Tahirov TH; Inoue-Bungo T; Morii H; Fujikawa A; Sasaki M; Kimura K; Shiina M; Sato K; Kumasaka T; Yamamoto M; Ishii S; Ogata K
    Cell; 2001 Mar; 104(5):755-67. PubMed ID: 11257229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of CBF alpha/AML/PEBP2 alpha transcription factors with nucleosomes containing promoter sequences requires flexibility in the translational positioning of the histone octamer and exposure of the CBF alpha site.
    Gutiérrez J; Sierra J; Medina R; Puchi M; Imschenetzky M; van Wijnen A; Lian J; Stein G; Stein J; Montecino M
    Biochemistry; 2000 Nov; 39(44):13565-74. PubMed ID: 11063594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALY, a context-dependent coactivator of LEF-1 and AML-1, is required for TCRalpha enhancer function.
    Bruhn L; Munnerlyn A; Grosschedl R
    Genes Dev; 1997 Mar; 11(5):640-53. PubMed ID: 9119228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the ELA2 gene encoding neutrophil elastase are present in most patients with sporadic severe congenital neutropenia but only in some patients with the familial form of the disease.
    Ancliff PJ; Gale RE; Liesner R; Hann IM; Linch DC
    Blood; 2001 Nov; 98(9):2645-50. PubMed ID: 11675333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PITX2, beta-catenin and LEF-1 interact to synergistically regulate the LEF-1 promoter.
    Vadlamudi U; Espinoza HM; Ganga M; Martin DM; Liu X; Engelhardt JF; Amendt BA
    J Cell Sci; 2005 Mar; 118(Pt 6):1129-37. PubMed ID: 15728254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ela2 mutations and clinical manifestations in familial congenital neutropenia.
    Shiohara M; Shigemura T; Saito S; Tanaka M; Yanagisawa R; Sakashita K; Asada H; Ishii E; Koike K; Chin M; Kobayashi M; Koike K
    J Pediatr Hematol Oncol; 2009 May; 31(5):319-24. PubMed ID: 19415009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LEF-1 is a decisive transcription factor in neutrophil granulopoiesis.
    Skokowa J; Welte K
    Ann N Y Acad Sci; 2007 Jun; 1106():143-51. PubMed ID: 17360796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoid enhancer-binding factor-1 binds and activates the recombination-activating gene-2 promoter together with c-Myb and Pax-5 in immature B cells.
    Jin ZX; Kishi H; Wei XC; Matsuda T; Saito S; Muraguchi A
    J Immunol; 2002 Oct; 169(7):3783-92. PubMed ID: 12244173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mice expressing a neutrophil elastase mutation derived from patients with severe congenital neutropenia have normal granulopoiesis.
    Grenda DS; Johnson SE; Mayer JR; McLemore ML; Benson KF; Horwitz M; Link DC
    Blood; 2002 Nov; 100(9):3221-8. PubMed ID: 12384420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assembly and function of a TCR alpha enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions.
    Giese K; Kingsley C; Kirshner JR; Grosschedl R
    Genes Dev; 1995 Apr; 9(8):995-1008. PubMed ID: 7774816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microphthalmia-associated transcription factor interacts with LEF-1, a mediator of Wnt signaling.
    Yasumoto K; Takeda K; Saito H; Watanabe K; Takahashi K; Shibahara S
    EMBO J; 2002 Jun; 21(11):2703-14. PubMed ID: 12032083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ELA2 is regulated by hematopoietic transcription factors, but not repressed by AML1-ETO.
    Lausen J; Liu S; Fliegauf M; Lübbert M; Werner MH
    Oncogene; 2006 Mar; 25(9):1349-57. PubMed ID: 16247445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct roles for P-CREB and LEF-1 in TCR alpha enhancer assembly and activation on chromatin templates in vitro.
    Mayall TP; Sheridan PL; Montminy MR; Jones KA
    Genes Dev; 1997 Apr; 11(7):887-99. PubMed ID: 9106660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt-3A/beta-catenin signaling induces transcription from the LEF-1 promoter.
    Filali M; Cheng N; Abbott D; Leontiev V; Engelhardt JF
    J Biol Chem; 2002 Sep; 277(36):33398-410. PubMed ID: 12052822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AML3/CBFalpha1 is required for androgen-specific activation of the enhancer of the mouse sex-limited protein (Slp) gene.
    Ning YM; Robins DM
    J Biol Chem; 1999 Oct; 274(43):30624-30. PubMed ID: 10521447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the HIV-1 enhancer by the LEF-1 HMG protein on nucleosome-assembled DNA in vitro.
    Sheridan PL; Sheline CT; Cannon K; Voz ML; Pazin MJ; Kadonaga JT; Jones KA
    Genes Dev; 1995 Sep; 9(17):2090-104. PubMed ID: 7657162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in the ELA2 gene correlate with more severe expression of neutropenia: a study of 81 patients from the French Neutropenia Register.
    Bellanné-Chantelot C; Clauin S; Leblanc T; Cassinat B; Rodrigues-Lima F; Beaufils S; Vaury C; Barkaoui M; Fenneteau O; Maier-Redelsperger M; Chomienne C; Donadieu J
    Blood; 2004 Jun; 103(11):4119-25. PubMed ID: 14962902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tcf binding sequence and position determines beta-catenin and Lef-1 responsiveness of MMP-7 promoters.
    Gustavson MD; Crawford HC; Fingleton B; Matrisian LM
    Mol Carcinog; 2004 Nov; 41(3):125-39. PubMed ID: 15457508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.